BV is a CD30-directed antibody–drug conjugate (ADC) that links an antineoplastic agent, monomethyl auristatin E (MMAE), to a monoclonal antibody that can direct MMAE to CD30-positive lymphoma cells (19). This evidence concerns the gene TNFRSF8 and lymphoma.